Clinical, MRI, and CSF Markers of Disability Progression in Multiple Sclerosis

  • Gajofatto A
  • Calabrese M
  • Benedetti M
  • et al.
N/ACitations
Citations of this article
98Readers
Mendeley users who have this article in their library.

Abstract

Multiple sclerosis (MS) is a chronic disorder of the central nervous system (CNS) in which the complex interplay between inflammation and neurodegeneration determines varying degrees of neurological disability. For this reason, it is very difficult to express an accurate prognosis based on purely clinical information in the individual patient at an early disease stage. Magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) biomarkers are promising sources of prognostic information with a good potential of quantitative measure, sensitivity, and reliability. However, a comprehensive MS outcome prediction model combining multiple parameters is still lacking. Current relevant literature addressing the topic of clinical, MRI, and CSF markers as predictors of MS disability progression is reviewed here.

Cite

CITATION STYLE

APA

Gajofatto, A., Calabrese, M., Benedetti, M. D., & Monaco, S. (2013). Clinical, MRI, and CSF Markers of Disability Progression in Multiple Sclerosis. Disease Markers, 35, 687–699. https://doi.org/10.1155/2013/484959

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free